Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Phytotherapy Research : PTR|August 15, 2013
Herbal therapeutics that block the oncogenic kinase PAK1: a practical approach towards PAK1-dependent diseases and longevityHiroshi Maruta
Medicine in Drug Discovery|April 22, 2020
PAK1-blockers: Potential Therapeutics against COVID-19Hiroshi Maruta, Hong He
Drug Discovery Today|April 30, 2020
Chemical evolution for taming the 'pathogenic kinase' PAK1Hiroshi Maruta, Atsushi Kittaka
Drug Discoveries & Therapeutics|April 3, 2024
Rapamycin vs TORin-1 or Gleevec vs Nilotinib: Simple chemical evolution that converts PAK1-blockers to TOR-blockers or vice versa?Hiroshi Maruta, Hong He
Drug Discoveries & Therapeutics|March 10, 2022
Probiotic microbes: Are their anti-melanogenicity and longevity promoting activities closely linked through the major "pathogenic" kinase PAK1?Hiroshi Maruta, Mok-Ryeon Ahn
European Journal of Medicinal Chemistry|August 18, 2017
From bench (laboratory) to bed (hospital/home): How to explore effective natural and synthetic PAK1-blockers/longevity-promoters for cancer therapyHiroshi Maruta, Mok-Ryeon Ahn
Progress in Cell Cycle Research|November 5, 2003
Rho family-associated kinases PAK1 and rockHiroshi Maruta, Thao V Nheu, Hong He, et al.
The Journal of Veterinary Medical Science|January 11, 2007
Bacteriological survey of mammary secretions from prepartum heifers in a dairy herd with a high prevalence of Staphylococcus aureus infectionHajime Nagahata, Hiroshi Maruta, Takeshi Okuhira, et al.
Cancer Research|February 7, 2002
Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblastsKiyohito Mizutani, Hiroaki Miki, Hong He, et al.
Cancer Biology & Therapy|August 6, 2005
Signal therapy of breast cancers by the HDAC inhibitor FK228 that blocks the activation of PAK1 and abrogates the tamoxifen-resistanceYumiko Hirokawa, Melissa Arnold, Hidenori Nakajima, et al.
Pageof 4